Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma Source: Eur Respir J 2016; 47: 792-800 Year: 2016
Chronic infection by nontypeable Haemophilus influenzae fuels airway inflammation Source: ERJ Open Res, 7 (1) 00614-2020; 10.1183/23120541.00614-2020 Year: 2021
Infection pattern and inflammatory response in acute and persistent nontypeable haemophilus influenzae (NTHi) infection of COPD lung tissue Source: Eur Respir J 2006; 28: Suppl. 50, 841s Year: 2006
Haemophilus influenzae in COPD patients with poorer lung function carry more antibiotic resistanceSource: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002
HI-164, an oral vaccine to non-typable haemophilus influenzae , reduces antibiotic use, respiratory exacerbations and hospitalisations in patients with COPD Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007
Haemophilus influenzae persists in biofilm communities in a smoke-exposed ferret model of COPDSource: ERJ Open Res, 6 (3) 00200-2020; 10.1183/23120541.00200-2020 Year: 2020
Chronic bronchial infection/colonisation: aetiology and mechanisms Source: Eur Respir Monogr 2013; 60: 34-45 Year: 2013
Clinical impact of a non-typeable Haemophilus influenzae (NTHi) adjuvanted vaccine in adults with chronic obstructive pulmonary disease (COPD) Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019
Alteration of the immune response to nontypeable haemophilus influenzae (NTHI) during COPD exacerbation in mice Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Specific immune response against Haemophilus influenzae in stable COPD Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD Year: 2010
Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016
Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Movement of Haemophilus influenzae types resistance isolated from sputum in patients with COPD in 2004 Source: Eur Respir J 2005; 26: Suppl. 49, 60s Year: 2005
Associations between haemophilus influenzae and levels of sputum antimicrobial peptides in COPD Source: International Congress 2016 – Translational research in respiratory infections Year: 2016
Non-typeable Haemophilus influenzae infection of ciliated epithelium from healthy and chronic obstructive pulmonary disease donors Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018
Establishment of Nontypeable Haemophilus influenzae airway infection murine model Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007
A subset of COPD patients defined by lung epithelial IL-6 trans-signalling is associated with neutrophilic inflammation and colonization by Haemophilus influenzae Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019
Mycoplasma pneumoniae infection of airways in patients with exacerbations of bronchial asthmaSource: Eur Respir J 2006; 28: Suppl. 50, 237s Year: 2006
Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) adjuvanted vaccine in older adults with chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018